Literature DB >> 26690290

Reproductive Health Needs Among Substance Use Disorder Treatment Clients.

Mishka Terplan1, Maayan Lawental, Melanie Bryant Connah, Caitlin Eileen Martin.   

Abstract

OBJECTIVES: Individuals with substance use disorders (SUDs) have unique reproductive health needs. The aim of this study was to evaluate these needs and assess the acceptability of family planning service delivery of SUD treatment clients.
METHODS: Reproductive health needs of drug treatment clients were assessed using a cross-sectional anonymous survey in 4 treatment sites in Baltimore City, MD. Surveys were distributed by staff. Contraceptives assessed included sterilization, intrauterine devices, implants, injections, pills, patches, rings, condoms, spermicide, withdrawal, and the rhythm method. Results are stratified by sex and between those using and not using highly effective contraceptive methods.
RESULTS: A total of 115 women and 95 men completed the survey (80% younger than 50 years), with 39% of women and 54% of men reporting using condoms, but only 24% of women and 26% of men reporting consistent use. All other methods were used by less than 12% of the sample. Only 20% of sexually active women reported using a highly reliable form of contraception and only 53% were using any form of contraception at all. Contraceptive use correlated inversely with age, but did not correlate with having had sexually transmitted infection testing or other preventive health services. Although more than 90% of participants had access to health care services in the past 3 years, 25% of women and 33% of men reported difficulty accessing health care providers. The majority of respondents said they would likely use family planning services if available at their SUD treatment (83% of women and 58% of men).
CONCLUSIONS: Men and women in SUD treatment have unmet reproductive health needs. As SUD treatment moves toward greater integration, the programmatic inclusion of family planning services should be considered.

Entities:  

Mesh:

Year:  2016        PMID: 26690290     DOI: 10.1097/ADM.0000000000000175

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  9 in total

1.  Perceptions of Pregnancy and Contraceptive Use: An In-Depth Study of Women in Los Angeles Methadone Clinics.

Authors:  Marta Bornstein; Jessica D Gipson; Roselle Bleck; Aparna Sridhar; Agatha Berger
Journal:  Womens Health Issues       Date:  2018-11-13

2.  A Comparison of Sex-Specific Reproductive and Sexual Health Needs between Addiction Medicine and Primary Care Treatment Settings.

Authors:  Caitlin E Martin; Anna Beth Parlier-Ahmad; Lori Beck; Vashali Jain; Mishka Terplan
Journal:  Subst Use Misuse       Date:  2022-05-23       Impact factor: 2.362

3.  Comprehensive Treatment for Pregnant and/or Parenting Women with Substance Use Disorders and Their Children: A Cross-Cultural Comparison.

Authors:  Hendrée Jones E; Stacey Klaman L; Catherine Leiner; Raquel da Silva Barros; Roberto Canay; Jesica Suarez V; Rocio Suarez Ordoñez M; Kevin O'Grady E
Journal:  J Subst Abus Alcohol       Date:  2021-01-23

4.  A mixed methods study exploring methadone treatment disclosure and perceptions of reproductive health care among women ages 18-44 years, Los Angeles, CA.

Authors:  Marta Bornstein; Agatha Berger; Jessica D Gipson
Journal:  J Subst Abuse Treat       Date:  2020-08-21

5.  Virtually possible: using telehealth to bring reproductive health care to women with opioid use disorder in rural Maine.

Authors:  Terri-Ann Thompson; Katherine A Ahrens; Leah Coplon
Journal:  Mhealth       Date:  2020-10-05

6.  Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation.

Authors:  Uma M Reddy; Jonathan M Davis; Zhaoxia Ren; Michael F Greene
Journal:  Obstet Gynecol       Date:  2017-07       Impact factor: 7.623

7.  Miscarriage and Abortion Among Women Attending Harm Reduction Services in Philadelphia: Correlations With Individual, Interpersonal, and Structural Factors.

Authors:  Joy D Scheidell; Janna Ataiants; Stephen E Lankenau
Journal:  Subst Use Misuse       Date:  2022-03-11       Impact factor: 2.362

Review 8.  Pre-exposure prophylaxis (PrEP) indication and uptake among people receiving buprenorphine for the treatment of opioid use disorder.

Authors:  Lori Beck; Anna Beth Parlier-Ahmad; Caitlin E Martin
Journal:  J Subst Abuse Treat       Date:  2021-05-31

9.  Increasing access to family planning services among women receiving medications for opioid use disorder: A pilot randomized trial examining a peer-led navigation intervention.

Authors:  Deborah J Rinehart; Melanie Stowell; Adriana Collings; M Joshua Durfee; Tara Thomas-Gale; Hendrée E Jones; Ingrid Binswanger
Journal:  J Subst Abuse Treat       Date:  2021-02-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.